Orthofix Medical Inc. (OFIX)
USD 14.56
(-6.34%)
USD 14.56
(-6.34%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -151.39 Million USD | -666.6% |
| 2022 | -19.74 Million USD | 48.54% |
| 2021 | -38.37 Million USD | -1624.79% |
| 2020 | 2.51 Million USD | 108.84% |
| 2019 | -28.46 Million USD | -306.08% |
| 2018 | 13.81 Million USD | 121.93% |
| 2017 | 6.22 Million USD | 103.63% |
| 2016 | 3.05 Million USD | 208.79% |
| 2015 | -2.8 Million USD | 67.1% |
| 2014 | -8.53 Million USD | 70.02% |
| 2013 | -28.47 Million USD | -155.51% |
| 2012 | 51.29 Million USD | 4880.52% |
| 2011 | -1.07 Million USD | -102.43% |
| 2010 | 44.2 Million USD | 80.65% |
| 2009 | 24.47 Million USD | 110.71% |
| 2008 | -228.55 Million USD | -2183.83% |
| 2007 | 10.96 Million USD | 255.75% |
| 2006 | -7.04 Million USD | -109.59% |
| 2005 | 73.4 Million USD | 114.95% |
| 2004 | 34.14 Million USD | 38.09% |
| 2003 | 24.73 Million USD | -4.57% |
| 2002 | 25.91 Million USD | 23.61% |
| 2001 | 20.96 Million USD | -53.22% |
| 2000 | 44.81 Million USD | 247.09% |
| 1999 | 12.91 Million USD | -9.71% |
| 1998 | 14.3 Million USD | 361.29% |
| 1997 | 3.1 Million USD | 720.0% |
| 1996 | -500 Thousand USD | 97.47% |
| 1995 | -19.8 Million USD | -317.58% |
| 1994 | 9.1 Million USD | 18.18% |
| 1993 | 7.7 Million USD | 24.19% |
| 1992 | 6.2 Million USD | 24.0% |
| 1991 | 5 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -33.44 Million USD | 7.15% |
| 2024 Q1 | -36.02 Million USD | -62.44% |
| 2023 Q1 | -60.93 Million USD | -762.9% |
| 2023 FY | -151.39 Million USD | -666.6% |
| 2023 Q2 | -39.42 Million USD | 35.3% |
| 2023 Q3 | -28.85 Million USD | 26.81% |
| 2023 Q4 | -22.17 Million USD | 23.16% |
| 2022 Q1 | -4.46 Million USD | 86.41% |
| 2022 Q3 | -10.71 Million USD | -530.53% |
| 2022 FY | -19.74 Million USD | 48.54% |
| 2022 Q2 | 2.48 Million USD | 155.81% |
| 2022 Q4 | -7.06 Million USD | 34.1% |
| 2021 FY | -38.37 Million USD | -1624.79% |
| 2021 Q1 | -5.81 Million USD | 37.98% |
| 2021 Q2 | 2.42 Million USD | 141.61% |
| 2021 Q3 | -2.17 Million USD | -189.71% |
| 2021 Q4 | -32.81 Million USD | -1411.38% |
| 2020 Q3 | 4.65 Million USD | 125.26% |
| 2020 Q1 | 25.66 Million USD | 119.62% |
| 2020 Q4 | -9.37 Million USD | -301.5% |
| 2020 FY | 2.51 Million USD | 108.84% |
| 2020 Q2 | -18.42 Million USD | -171.79% |
| 2019 Q1 | 897 Thousand USD | -89.89% |
| 2019 Q2 | -547 Thousand USD | -160.98% |
| 2019 Q3 | -40.49 Million USD | -7303.66% |
| 2019 Q4 | 11.68 Million USD | 128.86% |
| 2019 FY | -28.46 Million USD | -306.08% |
| 2018 Q4 | 8.87 Million USD | 832.54% |
| 2018 FY | 13.81 Million USD | 121.93% |
| 2018 Q2 | 925 Thousand USD | -82.3% |
| 2018 Q3 | -1.21 Million USD | -230.92% |
| 2018 Q1 | 5.22 Million USD | 233.29% |
| 2017 Q1 | -2.65 Million USD | 17.99% |
| 2017 Q4 | 1.56 Million USD | -54.63% |
| 2017 Q3 | 3.45 Million USD | -10.3% |
| 2017 FY | 6.22 Million USD | 103.63% |
| 2017 Q2 | 3.85 Million USD | 245.18% |
| 2016 FY | 3.05 Million USD | 208.79% |
| 2016 Q4 | -3.23 Million USD | -132.7% |
| 2016 Q1 | 3.89 Million USD | 15.55% |
| 2016 Q3 | 9.89 Million USD | 233.97% |
| 2016 Q2 | -7.38 Million USD | -289.75% |
| 2015 Q3 | -1.37 Million USD | -138.38% |
| 2015 Q1 | -8.37 Million USD | -44.52% |
| 2015 FY | -2.8 Million USD | 67.1% |
| 2015 Q2 | 3.57 Million USD | 142.63% |
| 2015 Q4 | 3.36 Million USD | 345.73% |
| 2014 Q1 | -782 Thousand USD | 92.78% |
| 2014 Q4 | -5.79 Million USD | -1382.74% |
| 2014 Q2 | -683 Thousand USD | 12.66% |
| 2014 FY | -8.53 Million USD | 70.02% |
| 2014 Q3 | 452 Thousand USD | 166.18% |
| 2013 Q3 | -19.82 Million USD | -755.5% |
| 2013 FY | -28.47 Million USD | -155.51% |
| 2013 Q4 | -10.83 Million USD | 45.33% |
| 2013 Q2 | -2.31 Million USD | -209.5% |
| 2013 Q1 | 2.11 Million USD | -89.69% |
| 2012 Q4 | 20.51 Million USD | 171.35% |
| 2012 FY | 51.29 Million USD | 4880.52% |
| 2012 Q1 | 12.01 Million USD | -3.03% |
| 2012 Q2 | 11.2 Million USD | -6.75% |
| 2012 Q3 | 7.56 Million USD | -32.53% |
| 2011 FY | -1.07 Million USD | -102.43% |
| 2011 Q4 | 12.39 Million USD | 0.11% |
| 2011 Q2 | 9.95 Million USD | 127.81% |
| 2011 Q3 | 12.37 Million USD | 24.3% |
| 2011 Q1 | -35.8 Million USD | -549.54% |
| 2010 FY | 44.2 Million USD | 80.65% |
| 2010 Q4 | 7.96 Million USD | -6.53% |
| 2010 Q1 | 17.49 Million USD | 84.89% |
| 2010 Q2 | 10.23 Million USD | -41.5% |
| 2010 Q3 | 8.52 Million USD | -16.73% |
| 2009 Q4 | 9.46 Million USD | 52.89% |
| 2009 Q3 | 6.18 Million USD | 4.1% |
| 2009 Q1 | 2.87 Million USD | 501.53% |
| 2009 Q2 | 5.94 Million USD | 106.46% |
| 2009 FY | 24.47 Million USD | 110.71% |
| 2008 Q4 | -717 Thousand USD | 99.7% |
| 2008 Q1 | 3.6 Million USD | 134.29% |
| 2008 Q2 | 5.8 Million USD | 61.06% |
| 2008 FY | -228.55 Million USD | -2183.83% |
| 2008 Q3 | -237.25 Million USD | -4184.9% |
| 2007 FY | 10.96 Million USD | 255.75% |
| 2007 Q4 | -10.51 Million USD | -230.98% |
| 2007 Q1 | 6.26 Million USD | -15.32% |
| 2007 Q3 | 8.02 Million USD | 11.67% |
| 2007 Q2 | 7.18 Million USD | 14.71% |
| 2006 Q2 | 12.72 Million USD | 54.35% |
| 2006 FY | -7.04 Million USD | -109.59% |
| 2006 Q4 | 7.4 Million USD | 120.9% |
| 2006 Q1 | 8.24 Million USD | 14.58% |
| 2006 Q3 | -35.41 Million USD | -378.26% |
| 2005 Q2 | 9.4 Million USD | -12.75% |
| 2005 FY | 73.4 Million USD | 114.95% |
| 2005 Q4 | 7.19 Million USD | -84.36% |
| 2005 Q3 | 46.02 Million USD | 389.31% |
| 2005 Q1 | 10.77 Million USD | 13.31% |
| 2004 Q1 | 8.34 Million USD | 21.97% |
| 2004 Q3 | 8.41 Million USD | 6.88% |
| 2004 Q2 | 7.87 Million USD | -5.62% |
| 2004 Q4 | 9.51 Million USD | 13.02% |
| 2004 FY | 34.14 Million USD | 38.09% |
| 2003 Q3 | 5.44 Million USD | -16.21% |
| 2003 FY | 24.73 Million USD | -4.57% |
| 2003 Q1 | 5.95 Million USD | -9.45% |
| 2003 Q2 | 6.49 Million USD | 9.1% |
| 2003 Q4 | 6.84 Million USD | 25.71% |
| 2002 Q3 | 5.97 Million USD | -11.84% |
| 2002 Q1 | 6.59 Million USD | 10.15% |
| 2002 Q2 | 6.77 Million USD | 2.82% |
| 2002 FY | 25.91 Million USD | 23.61% |
| 2002 Q4 | 6.57 Million USD | 10.04% |
| 2001 Q4 | 5.98 Million USD | 20.02% |
| 2001 Q3 | 4.98 Million USD | -1.56% |
| 2001 Q1 | 4.93 Million USD | 4.69% |
| 2001 Q2 | 5.06 Million USD | 2.7% |
| 2001 FY | 20.96 Million USD | -53.22% |
| 2000 Q1 | 32.06 Million USD | 741.24% |
| 2000 Q4 | 4.71 Million USD | 21.33% |
| 2000 Q3 | 3.88 Million USD | -6.59% |
| 2000 FY | 44.81 Million USD | 247.09% |
| 2000 Q2 | 4.15 Million USD | -87.04% |
| 1999 FY | 12.91 Million USD | -9.71% |
| 1999 Q2 | 3.2 Million USD | 14.29% |
| 1999 Q4 | 3.81 Million USD | 22.97% |
| 1999 Q3 | 3.1 Million USD | -3.13% |
| 1999 Q1 | 2.8 Million USD | -64.1% |
| 1998 Q3 | 2.4 Million USD | 0.0% |
| 1998 FY | 14.3 Million USD | 361.29% |
| 1998 Q4 | 7.8 Million USD | 225.0% |
| 1998 Q1 | 1.7 Million USD | -29.17% |
| 1998 Q2 | 2.4 Million USD | 41.18% |
| 1997 Q2 | -500 Thousand USD | 16.67% |
| 1997 FY | 3.1 Million USD | 720.0% |
| 1997 Q4 | 2.4 Million USD | 41.18% |
| 1997 Q3 | 1.7 Million USD | 440.0% |
| 1997 Q1 | -600 Thousand USD | 66.67% |
| 1996 Q3 | 400 Thousand USD | -42.86% |
| 1996 Q4 | -1.8 Million USD | -550.0% |
| 1996 Q2 | 700 Thousand USD | 133.33% |
| 1996 FY | -500 Thousand USD | 97.47% |
| 1996 Q1 | 300 Thousand USD | 114.29% |
| 1995 FY | -19.8 Million USD | -317.58% |
| 1995 Q4 | -2.1 Million USD | 90.95% |
| 1995 Q1 | 2.9 Million USD | 3.57% |
| 1995 Q2 | 2.6 Million USD | -10.34% |
| 1995 Q3 | -23.2 Million USD | -992.31% |
| 1994 Q4 | 2.8 Million USD | 27.27% |
| 1994 Q2 | 2.1 Million USD | 0.0% |
| 1994 Q1 | 2.1 Million USD | 0.0% |
| 1994 FY | 9.1 Million USD | 18.18% |
| 1994 Q3 | 2.2 Million USD | 4.76% |
| 1993 Q4 | 2.1 Million USD | 10.53% |
| 1993 FY | 7.7 Million USD | 24.19% |
| 1993 Q3 | 1.9 Million USD | 5.56% |
| 1993 Q2 | 1.8 Million USD | 0.0% |
| 1993 Q1 | 1.8 Million USD | 5.88% |
| 1992 Q1 | 1.5 Million USD | 36.36% |
| 1992 FY | 6.2 Million USD | 24.0% |
| 1992 Q4 | 1.7 Million USD | 0.0% |
| 1992 Q3 | 1.7 Million USD | 30.77% |
| 1992 Q2 | 1.3 Million USD | -13.33% |
| 1991 Q3 | 1.3 Million USD | 0.0% |
| 1991 FY | 5 Million USD | 0.0% |
| 1991 Q1 | 1.3 Million USD | 0.0% |
| 1991 Q2 | 1.3 Million USD | 0.0% |
| 1991 Q4 | 1.1 Million USD | -15.38% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | -145.699% |
| BrainsWay Ltd. | -4.19 Million USD | -3507.219% |
| Cerus Corporation | -37.48 Million USD | -303.838% |
| Envoy Medical, Inc. | -29.9 Million USD | -406.202% |
| electroCore, Inc. | -18.83 Million USD | -703.839% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -1610.678% |
| IceCure Medical Ltd | -14.65 Million USD | -933.272% |
| Inogen, Inc. | -102.44 Million USD | -47.776% |
| OrthoPediatrics Corp. | -20.97 Million USD | -621.822% |
| Lucid Diagnostics Inc. | -52.66 Million USD | -187.462% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -1001.438% |
| MaxCyte, Inc. | -37.92 Million USD | -299.217% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -1176.572% |
| Nexalin Technology, Inc. | -4.64 Million USD | -3156.711% |
| PAVmed Inc | -64.17 Million USD | -135.91% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | -188.553% |
| RxSight, Inc. | -48.6 Million USD | -211.461% |
| Sight Sciences, Inc. | -55.54 Million USD | -172.553% |
| SI-BONE, Inc. | -43.33 Million USD | -249.352% |
| TELA Bio, Inc. | -46.66 Million USD | -224.436% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | -205.682% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -1014.592% |
| Acutus Medical, Inc. | -81.66 Million USD | -85.39% |
| Talis Biomedical Corporation | -62 Million USD | -144.158% |
| Spectral AI, Inc. | -20.85 Million USD | -625.976% |
| Nano-X Imaging Ltd. | -60.77 Million USD | -149.103% |
| CVRx, Inc. | -41.19 Million USD | -267.473% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 23748.226% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -1281.934% |
| Bioventus Inc. | -156.23 Million USD | 3.095% |
| Venus Concept Inc. | -37.25 Million USD | -306.43% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | -156.437% |
| LivaNova PLC | 17.54 Million USD | 962.846% |
| 908 Devices Inc. | -36.39 Million USD | -315.932% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 18.883% |
| Nemaura Medical Inc. | -14.14 Million USD | -970.403% |
| NeuroPace, Inc. | -32.95 Million USD | -359.385% |
| LENSAR, Inc. | -14.38 Million USD | -952.597% |
| Apyx Medical Corporation | -18.71 Million USD | -709.036% |
| Cutera, Inc. | -162.83 Million USD | 7.024% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -1297.922% |
| BioSig Technologies, Inc. | -29.04 Million USD | -421.315% |
| Anika Therapeutics, Inc. | -82.66 Million USD | -83.138% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | -585.386% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 323.491% |
| Axonics, Inc. | -6.08 Million USD | -2386.777% |
| Outset Medical, Inc. | -172.79 Million USD | 12.386% |
| IRIDEX Corporation | -9.57 Million USD | -1481.975% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | -42.964% |
| IRadimed Corporation | 17.19 Million USD | 980.573% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -1736.426% |
| INVO Bioscience, Inc. | -8.03 Million USD | -1784.285% |
| Telesis Bio, Inc. | -47.72 Million USD | -217.23% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 1578.034% |
| Varex Imaging Corporation | -47.7 Million USD | -217.39% |
| Quipt Home Medical Corp. | -2.78 Million USD | -5338.039% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -1241.441% |
| Pulmonx Corporation | -60.84 Million USD | -148.829% |
| Dynatronics Corporation | -2.69 Million USD | -5511.963% |
| Modular Medical, Inc. | -17.47 Million USD | -766.6% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -1229.542% |
| Semler Scientific, Inc. | 20.58 Million USD | 835.534% |
| InMode Ltd. | 197.91 Million USD | 176.493% |
| Bruker Corporation | 427.2 Million USD | 135.439% |
| Cytosorbents Corporation | -28.5 Million USD | -431.073% |
| DexCom, Inc. | 541.5 Million USD | 127.958% |
| Align Technology, Inc. | 445.05 Million USD | 134.017% |
| Viveve Medical, Inc. | -22.02 Million USD | -587.316% |
| ZimVie Inc. | -393.28 Million USD | 61.505% |
| Movano Inc. | -29.28 Million USD | -417.006% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -1146.255% |
| Nexalin Technology, Inc. | -4.64 Million USD | -3156.711% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 23748.226% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 31.991% |
| Profound Medical Corp. | -28.56 Million USD | -429.928% |
| Insulet Corporation | 206.3 Million USD | 173.386% |
| enVVeno Medical Corporation | -23.51 Million USD | -543.796% |
| Surmodics, Inc. | -11.54 Million USD | -1211.688% |
| iCAD, Inc. | -4.84 Million USD | -3023.478% |
| Nuwellis, Inc. | -20.2 Million USD | -649.146% |
| Biotricity, Inc. | -14.09 Million USD | -974.159% |
| iRhythm Technologies, Inc. | -123.4 Million USD | -22.68% |
| Aethlon Medical, Inc. | -12.2 Million USD | -1140.112% |
| InspireMD, Inc. | -19.91 Million USD | -660.168% |
| PAVmed Inc. | -64.17 Million USD | -135.91% |
| BIOLASE, Inc. | -20.63 Million USD | -633.787% |
| Beyond Air, Inc. | -60.24 Million USD | -151.311% |
| FONAR Corporation | 10.56 Million USD | 1532.661% |
| AxoGen, Inc. | -21.71 Million USD | -597.159% |
| Vivani Medical, Inc. | -25.65 Million USD | -490.188% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 630.931% |
| Inari Medical, Inc. | -1.63 Million USD | -9153.973% |
| UFP Technologies, Inc. | 44.92 Million USD | 437.002% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -2849.829% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -2192.055% |
| Tenon Medical, Inc. | -15.58 Million USD | -871.664% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -881.427% |
| Co-Diagnostics, Inc. | -35.33 Million USD | -328.482% |
| AdaptHealth Corp. | -678.89 Million USD | 77.7% |
| Sintx Technologies, Inc. | -8.25 Million USD | -1733.091% |
| NanoVibronix, Inc. | -3.71 Million USD | -3979.628% |
| Quanterix Corporation | -32.33 Million USD | -368.222% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -1241.441% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 31315.464% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 50.643% |
| TransMedics Group, Inc. | -25.02 Million USD | -504.903% |
| ReWalk Robotics Ltd. | -22.13 Million USD | -584.024% |
| NeuroMetrix, Inc. | -6.52 Million USD | -2218.635% |
| Hyperfine, Inc. | -44.23 Million USD | -242.228% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | -92.855% |
| Biomerica, Inc. | -5.97 Million USD | -2432.536% |
| Bone Biologics Corporation | -8.94 Million USD | -1591.804% |
| AVITA Medical, Inc. | -39.16 Million USD | -286.525% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -1420.963% |
| Silk Road Medical, Inc | -55.74 Million USD | -171.595% |